Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1996
06/18/1996US5527805 Dna-cleaving, cytotoxic and anti-tumor compounds
06/18/1996US5527804 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors or cholesterol absorption
06/18/1996US5527803 Immunosuppressants, phosphorylase inhibitors
06/18/1996US5527802 New uses of 3-tetrazolo -5,6,7,8- substituted-pyrido (1,2-a) pyrimidin-4-ones
06/18/1996US5527801 Ameliorant for blood lipid metabolism
06/18/1996US5527799 HIV protease inhibitors useful for the treatment of AIDS
06/18/1996US5527797 Process for transport of agents across the skin and compositions and articles useful therein
06/18/1996US5527793 Antibiotic carbapenem compounds
06/18/1996US5527791 Carbapenem antibiotic compounds
06/18/1996US5527790 Hypoglycemic acents, antidiabetic agents
06/18/1996US5527789 Administering a ubiquinone to combat heart failure
06/18/1996US5527788 Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
06/18/1996US5527787 Combination of chlorambucil, melphalan, procarbazine hydrochloride, cyclophsphamide, liothyronine and calcium, used for immunostimulation
06/18/1996US5527785 Selectin receptor modulating compositions
06/18/1996US5527784 Antihyperlipidemic and antiobesity agent comprising levan or hydrolysis products thereof obtained from Streptococcus salivarius
06/18/1996US5527781 Aminoglycoside antibiotics
06/18/1996US5527780 Bactericides
06/18/1996US5527779 Blended with corticosteroid; treating psoriasis, rheumatoid arthritis
06/18/1996US5527777 Peptide compounds, in particular LHRH-antagonists
06/18/1996US5527700 Target antigens of transmission blocking antibodies for malaria parasites
06/18/1996US5527548 Promotes digestibility of food product having acid character
06/18/1996US5527545 Naproxen
06/18/1996US5527543 A carrier comprising diluent and binder; a film coating comprising a steroid and a lubricant
06/18/1996US5527540 Effervescent granules covering active material, such as ace inhibitor
06/18/1996US5527539 Tablets with thioctic acid of specific particle size
06/18/1996US5527533 Method of retarding and ameliorating central nervous system and eye damage
06/18/1996US5527530 Alcoholic moisturizing after shave lotion
06/18/1996US5527523 Hydroquinone amino-acid esters, methods of preparation, and pharmaceutical or cosmetic compositions containing them
06/18/1996CA2076003C Photostable cosmetic filtering composition containing a uv-a filter and an alkyl beta,beta-diphenylacrylate or o-cyano-beta,beta- diphenylacrylate
06/18/1996CA2063499C Ingestible polymeric phosphonium salts for the lowering of blood cholesterol
06/18/1996CA2038852C Ingestible amine functionalized and cross-linked homopolymers with hydrophobic backbone for the lowering of blood cholesterol
06/18/1996CA2022681C 2-(2-vinylpyrrolidinylthio)carbapenem derivatives
06/18/1996CA2020878C Antitumor antibiotic bu-3285t
06/18/1996CA1338399C Stabilized pharmaceutical composition and its production
06/18/1996CA1338376E Regimen for treating osteoporosis
06/17/1996CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase
06/17/1996CA2165131A1 Use of 1,2-bridged 1,4-dihydropyridines as medicaments
06/17/1996CA2165130A1 Use of 5-acyl-1,4-dihydropyridines
06/16/1996CA2165129A1 Thienopyridones
06/15/1996CA2165133A1 Substituted 1h-imidazoles
06/15/1996CA2164916A1 Vitamin d compounds and method of preparing these compounds
06/15/1996CA2164163A1 Diarylheptanoide derivative and pharmaceutical composition comprising the same
06/15/1996CA2155627A1 Thiazine- or thiazepine-derivatives
06/14/1996CA2164921A1 Method of treating anemia
06/14/1996CA2158511A1 Pharmaceutical formulations of cefaclor
06/13/1996WO1996017951A2 Identification of genes responsible for in vivo survival of microorganisms
06/13/1996WO1996017936A2 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017856A1 Synthesis of bidentate phosphines
06/13/1996WO1996017855A1 Anti-tumour agents
06/13/1996WO1996017850A1 Cephem compounds and pharmaceutical use thereof
06/13/1996WO1996017849A1 7-alkylidene cephalosporanic acid derivatives and methods of using the same
06/13/1996WO1996017845A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996WO1996017844A1 Novel porphyrins and porphyrin synthesis techniques
06/13/1996WO1996017842A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
06/13/1996WO1996017838A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996WO1996017833A1 Bicyclic fibrinogen antagonists
06/13/1996WO1996017831A1 Uracil derivatives
06/13/1996WO1996017830A1 Compounds for inhibition of gastric acid secretion
06/13/1996WO1996017827A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE β-ALANINE UREA ANALOGS
06/13/1996WO1996017819A1 Asiatic acid derivatives, its manufacturing method and dermatological agent containing it
06/13/1996WO1996017814A1 Halofluorocarbon hydrogenolysis
06/13/1996WO1996017624A1 Sunscreen-wound healing composition
06/13/1996WO1996017623A1 Anti-aids drug
06/13/1996WO1996017616A1 Kit for osteoporosis treatment cycle
06/13/1996WO1996017615A1 Viscous liquid conditioning topical germicides
06/13/1996WO1996017613A1 Hepatic-directed compounds and reagents for preparation thereof
06/13/1996WO1996017612A1 Use of substituted phenylamidine and phenylguanidine compounds for the treatment of cerebral and cardiac ischaemia, convulsion and sickle cell anaemia
06/13/1996WO1996017611A1 Pharmaceutical composition comprising lamotrigine
06/13/1996WO1996017610A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents
06/13/1996WO1996017609A1 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma
06/13/1996WO1996017608A1 Use of guanylate cyclase inhibitors for reducing intraocular pressure
06/13/1996WO1996017607A1 Method of producing a pantoprazol lyophilisate
06/13/1996WO1996017606A1 Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage
06/13/1996WO1996017605A1 Use of andrographolide compounds to treat or prevent pathogenicity of diseases
06/13/1996WO1996017604A1 Use of a nitric oxide (no) donor for the treatment of hypertension during pregnancy
06/13/1996WO1996017603A1 Emulsion suitable for administering a sphingolipid and use thereof
06/13/1996WO1996017602A1 A method for enhancing outflow of aqueous humor in treatment of glaucoma
06/13/1996WO1996017601A1 Compositions containing c4 alpha-ketoacids for treating corns and calluses
06/13/1996WO1996017600A1 PROTEIN PHOSPHATASE INHIBITION OF TUMOR NECROSIS FACTOR EFFECTS AND NF-kB ACTIVATION
06/13/1996WO1996017598A1 Diltiazem hydrochloride formulation
06/13/1996WO1996013263A3 Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis
06/13/1996WO1996012697A3 Calcium receptor-active compounds
06/13/1996WO1996011021A3 Treatment of tissues to reduce subsequent response to injury
06/13/1996WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation
06/13/1996WO1996006620A3 Lipid analogs for treating viral infections
06/13/1996WO1994013260A3 Use of a simarouba extract to reduce patchy skin pigmentation
06/13/1996DE19514522C1 Sauerstoffanionradikale enthaltende therapeutische Mittel und deren Verwendung zur Schmerzbehandlung Sauerstoffanionradikale containing therapeutic agents and their use for the treatment of pain
06/13/1996CA2208148A1 Novel porphyrins and porphyrin synthesis techniques
06/13/1996CA2207299A1 Anti-tumour agents
06/13/1996CA2207284A1 Pharmaceutical composition comprising lamotrigine
06/13/1996CA2207269A1 Use of xanthine oxidase inhibitors as anti-ischaemic agents
06/13/1996CA2207201A1 Azetidine, pyrrolidine and piperidine derivatives as 5ht1 receptor agonists
06/13/1996CA2207096A1 Hepatic-directed compounds and reagents for preparation thereof
06/13/1996CA2207028A1 Kit for osteoporosis treatment cycle
06/13/1996CA2206965A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996CA2206665A1 Malonic acid based matrix metalloproteinase inhibitors
06/13/1996CA2206664A1 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
06/13/1996CA2206640A1 Human vascular ibp-like growth factor
06/13/1996CA2205896A1 Compounds for inhibition of gastric acid secretion
1 ... 6908 6909 6910 6911 6912 6913 6914 6915 6916 6917 6918 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 ... 7860